← Back to Clinical Trials
Recruiting NCT07672067

NCT07672067 Intervention to Improve Parent Communication About Sexuality

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07672067
Status Recruiting
Phase
Sponsor University of Pennsylvania
Condition Sexual Health
Study Type INTERVENTIONAL
Enrollment 476 participants
Start Date 2026-05-01
Primary Completion 2028-12-30

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
Parents ASSIST

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 476 participants in total. It began in 2026-05-01 with a primary completion date of 2028-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study is centered on helping parents answer and meet the sexuality-specific questions and needs of gay or bisexual males. This study seeks to test the efficacy of Parents ASSIST as a parent-child sexuality communication intervention that educates and trains parents to be purveyors of inclusive health information as gay or bisexual sons come of age at home.

Eligibility Criteria

Youth participants (1) identify as a cisgender sexual minority male (e.g., gay, bisexual or queer) who has disclosed sexual orientation to parent or trusted caregiver (2) be aged 14-18 years; (3) able to comprehend spoken English; (4) resides in the United States; (5) consents or assents to study participation Parent participants (1) parent, legal guardians, legal custodians (hereinafter "parent") of GBQ adolescent; (2) age 18 or older; (3) able to comprehend spoken English; (4) resides in the United States; (5) knows their GBQ child's sexual orientation (6) consents to study participation; and (7) consents to their GBQ child's study participation.

Contact & Investigator

Central Contact

Dalmacio D Flores, PhD

✉ dalmacio@nursing.upenn.edu

📞 4043944593

Principal Investigator

Dalmacio D Flores, PhD

PRINCIPAL INVESTIGATOR

University of Pennsylvania

Frequently Asked Questions

Who can join the NCT07672067 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 100 Years, studying Sexual Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07672067 currently recruiting?

Yes, NCT07672067 is actively recruiting participants. Contact the research team at dalmacio@nursing.upenn.edu for enrollment information.

Where is the NCT07672067 trial being conducted?

This trial is being conducted at Philadelphia, United States.

Who is sponsoring the NCT07672067 clinical trial?

NCT07672067 is sponsored by University of Pennsylvania. The principal investigator is Dalmacio D Flores, PhD at University of Pennsylvania. The trial plans to enroll 476 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology